Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 8/20 | 0.39 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.39 |
| ▸ | BPTF | Q12830 | 9/20 | 0.37 |
| ▸ | BRD9 | Q9H8M2 | 5/20 | 0.36 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.36 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.34 |
| ▸ | BCL6 | P41182 | 1/20 | 0.33 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.33 |
| ▸ | PFKFB3 | Q16875 | 2/20 | 0.33 |
| ▸ | WEE1 | P30291 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31735682 | 0.93 | BRD4 (0.39) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735728 | 0.93 | BRD4 (0.39) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735773 | 0.93 | BRD4 (0.39) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735652 | 0.91 | BRD4 (0.40) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735476 | 0.89 | BRD4 (0.40) | BRD4BPTFBRD9KAT2BWEE1 | |
| SCHEMBL31735439 | 0.88 | P2RX3 (0.41) | BPTFWEE1 | |
| SCHEMBL31735740 | 0.85 | TBK1 (0.38) | BRD4BPTFBRD9KAT2BWEE1 | |
| SCHEMBL31735692 | 0.85 | EGFR (0.37) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735533 | 0.85 | EGFR (0.37) | BRD4CREBBPBPTFBRD9KAT2B | |
| SCHEMBL31735471 | 0.84 | BPTF (0.40) | BRD4BPTFBRD9KAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |